Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-13-000261

← back to feed
Filed
Aug 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jun 30, 2013 150M sh
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$1.24M
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$35.39K
Stockholders Equity Q2 2013 · Jun 30, 2013 −$2.49M
Stockholders Equity Q2 2013 · Dec 31, 2012 −$2.3M
Total Liabilities Q2 2013 · Jun 30, 2013 $2.97M
Total Liabilities Q2 2013 · Dec 31, 2012 $2.79M
Current Assets Q2 2013 · Jun 30, 2013 $485
Current Assets Q2 2013 · Dec 31, 2012 $701
Total Assets Q2 2013 · Jun 30, 2013 $482.14K
Total Assets Q2 2013 · Dec 31, 2012 $485.2K
Sga Expense Q2 2013 · Jun 30, 2013 $2.31M
Sga Expense Q2 2013 · Jun 30, 2012 $78.96K
Sga Expense Q2 2013 · Jun 30, 2012 $163.78K
Net Income Q2 2013 · Jun 30, 2013 −$2.48M
Net Income Q2 2013 · Jun 30, 2012 −$80.22K
Net Income Q2 2013 · Jun 30, 2012 −$170.36K
Cash And Equivalents Q2 2013 · Jun 30, 2012 $487
Cash And Equivalents Q2 2013 · Dec 31, 2011 $3.94K